Corporate Equity Investing In Biotech: Enriching For Success

For startup and emerging biotech companies, corporate venture capital and direct corporate equity investing are critically important contributors on the spectrum of funding sources--and over the past fifteen years, their involvement as investors in young biotech companies appears to correlate with a significant enrichment for successful “exit” outcomes.